Search

Your search keyword '"Dono M"' showing total 105 results

Search Constraints

Start Over You searched for: Author "Dono M" Remove constraint Author: "Dono M" Language english Remove constraint Language: english
105 results on '"Dono M"'

Search Results

3. The storm of NGS in NSCLC diagnostic-therapeutic pathway: How to sun the real clinical practice

5. ItaLynch: an ongoing Italian study to evaluate the feasibility of mainstreaming the diagnosis of Lynch syndrome in colorectal cancer patients

9. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

19. Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma.

20. CD10 is a marker for cycling cells with propensity to apoptosis in childhood ALL.

22. Report from the OECI Oncology Days 2014.

23. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

24. Report from the OECI Oncology days 2014

25. miR-15 and miR-16 induce apoptosis by targeting BCL2

26. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues

27. Streamlining the diagnostic pathway for Lynch syndrome in colorectal cancer patients: a 10-year experience in a single Italian Cancer Center.

28. BRAF V600E immunohistochemistry can reliably substitute BRAF molecular testing in the Lynch syndrome screening algorithm in colorectal cancer.

29. Collective action against corruption in Western and non-Western countries: cross-cultural implications of the Axiological-Identitary Collective Action Model.

30. 'Only My Truth Can Save Us All': The Impact of Socioeconomic Threat and its Emotional Appraisals on the Monopoly on Truth and Political Extremism.

31. Front-line liquid biopsy for early molecular assessment and treatment of hospitalized lung cancer patients.

32. Stem-like signatures in human meningioma cells are under the control of CXCL11/CXCL12 chemokine activity.

33. The spectrum of subclonal TP53 mutations in chronic lymphocytic leukemia: A next generation sequencing retrospective study.

34. A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients.

35. Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast Cancer.

36. Potential application of cryobiopsy for histo-molecular characterization of mediastinal lymph nodes in patients with thoracic malignancies: a case presentation series and implications for future developments.

37. The storm of NGS in NSCLC diagnostic-therapeutic pathway: How to sun the real clinical practice.

38. The Opportunities and Challenges of Molecular Tagging Next-Generation Sequencing in Liquid Biopsy.

39. Predicting Collective Action in a Secessionist Context: Different Motives for Two Opposed Stances.

40. Radiomic Detection of EGFR Mutations in NSCLC.

41. Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients.

42. TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors.

43. Optimization of a WGA-Free Molecular Tagging-Based NGS Protocol for CTCs Mutational Profiling.

44. An H- TERT Mutated Skin Metastasis as First Occurrence in a Case of Follicular Thyroid Carcinoma.

45. Axiological-Identitary Collective Action Model (AICAM): A new integrative perspective in the analysis of protest.

46. Tag-based next generation sequencing: a feasible and reliable assay for EGFR T790M mutation detection in circulating tumor DNA of non small cell lung cancer patients.

47. Development and validation of the Monopoly on Truth Scale. A measure of political extremism.

48. The Importance of Protesters' Morals: Moral Obligation as a Key Variable to Understand Collective Action.

49. Cytokines can counteract the inhibitory effect of MEK-i on NK-cell function.

50. BRAF Mutations in an Italian Regional Population: Implications for the Therapy of Thyroid Cancer.

Catalog

Books, media, physical & digital resources